ADAMA Ltd
SZSE:000553

Watchlist Manager
ADAMA Ltd Logo
ADAMA Ltd
SZSE:000553
Watchlist
Price: 6.21 CNY -1.27% Market Closed
Market Cap: ¥14.5B

ADAMA Ltd
Investor Relations

In the vast realm of global agriculture, ADAMA Ltd. stands as a notable and innovative player, intricately weaving its operations from the fertile fields of Israel to the expansive farmlands worldwide. Born from agronomic expertise and an enduring commitment to the farming community, ADAMA specializes in crop protection products. Their robust portfolio encompasses herbicides, insecticides, and fungicides, which are crafted to safeguard crops from pests and diseases, ultimately boosting farmers’ yields and ensuring food stability. These products undergo rigorous research and development, deep-rooted in scientific and environmental considerations, enabling the company to effectively address the diverse challenges faced by modern agriculture.

The company's business model thrives on a layered strategy. ADAMA blends global research capabilities with local insights to tailor solutions specific to regional agricultural needs. By maintaining a flexible but streamlined supply chain and distribution network, it optimizes logistics to provide timely product availability across various markets. Sales are further bolstered through collaborations with distributors and direct engagement with end-users. This regional-centric approach, coupled with a robust pipeline of new products and formulations, allows ADAMA not only to safeguard crops but also to grow its bottom line, making it a linchpin in the sophisticated ecosystem of agricultural sustainability.

Show more
Loading
000553
Shanghai Composite
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q2 2025
Call Date
Aug 27, 2025
AI Summary
Q2 2025

EBITDA Growth: ADAMA delivered its fifth straight quarter of EBITDA growth, with Q2 EBITDA up 19% year-on-year and H1 EBITDA up nearly 20%.

Margin Expansion: Both gross margin and EBITDA margin improved, with Q2 gross margin rising to 29.0% (from 26%) and EBITDA margin reaching 12.2%.

Return to Top-Line Growth: Q2 marked the first quarter of sales growth since Q3 2022, as volume gains outpaced ongoing price declines.

Cash Flow: Free cash flow improved by $24 million year-on-year, reaching $32 million in H1 2025.

Regional Performance: North America saw strong growth, while challenges persisted in Latin America (pricing pressure) and India (channel restructuring).

Transformation Progress: Management emphasized the impact of the Fight Forward plan, including cost reductions, portfolio optimization, and enhanced commercial execution.

Market Headwinds: Oversupply from China and weak farmer profitability continue to create price pressure industry-wide.

Key Financials
Sales
$968 million
Sales
$1.8 billion
Gross Margin
29.0%
Gross Margin
around 30% in H1 2025
EBITDA
$180 million in Q2 2025
EBITDA
$244 million in H1 2025
EBITDA Margin
12.2% in Q2 2025
Free Cash Flow
$32 million in H1 2025
Net Profit
$43 million (reported) in Q2 2025
Net Profit
$34 million (reported) in H1 2025
Adjusted Net Profit
$22 million in H1 2025
Net Debt-to-EBITDA Ratio
2.5
Total Debt
$2.2 billion
Bonds Outstanding
$784 million
Unused Committed Credit Lines
$580 million
Earnings Call Recording
Other Earnings Calls

Management

Ms. Efrat Nagar
Executive VP & CFO
No Bio Available
Mr. An Liru
Executive VP of China & Non-Independent Director
No Bio Available
Mr. Elad Shabtai
Executive Vice President of Formulation Supply
No Bio Available
Mr. Sergio Dedominici Paz
Executive Vice President of Europe, Africa & Middle East
No Bio Available
Mr. Gael Hili
CEO & President
No Bio Available
Rivka Neufeld
Global Investor Relations Manager
No Bio Available
Ms. Ruthie Zeltzer
Executive Vice President of People
No Bio Available
Mr. David Peters
Executive Vice President of Asia Pacific
No Bio Available
Mr. Romeu Stanguerlin
Executive Vice President of Latin America
No Bio Available
Mr. Jake Brodsgaard
Executive Vice President of North America
No Bio Available

Contacts

Address
HUBEI
Jingzhou
No. 93, Beijing East Road
Contacts
+861056718110
www.adama.com
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett